165 related articles for article (PubMed ID: 4907391)
21. Comparison of efficacy of a new butyrophenone derivative, timiperone and perphenazine in schizophrenia by a multicentre controlled study.
Takahashi R; Inanaga K; Samejima K; Sarai K; Asada S; Otsuki S; Nakano S
J Int Med Res; 1982; 10(4):257-67. PubMed ID: 6126413
[TBL] [Abstract][Full Text] [Related]
22. Trifluperidol in Huntington's chorea.
Tarighati S; a'Brook MF
Lancet; 1968 Aug; 2(7565):458-9. PubMed ID: 4174183
[No Abstract] [Full Text] [Related]
23. Sympatholytic treatment of "paralytic" ileus.
Petri G; Szenohradszky J; Porszasz-Gibiszer K
Surgery; 1971 Sep; 70(3):359-67. PubMed ID: 5568520
[No Abstract] [Full Text] [Related]
24. A new butyrophenone: trifluperidol. A psychiatric evaluation in a pediatric setting.
Le Vann LJ
Can Psychiatr Assoc J; 1968 Jun; 13(3):271-3. PubMed ID: 5661691
[No Abstract] [Full Text] [Related]
25. Assessment of antipsychotic activity of a butyrophenone analogue, lenperone (AHR 2277).
Sathanathan GL; Angrist BM; Phillips N; Gershon S
Curr Ther Res Clin Exp; 1974 Aug; 16(8):844-7. PubMed ID: 4217252
[No Abstract] [Full Text] [Related]
26. Comparison of the short-term therapeutic effect of oxyprothepine and perphenazine in schizophrenic patients. A controlled study.
Svestka J; Rodovà A; Nàhunek K
Act Nerv Super (Praha); 1973 May; 15(2):103-4. PubMed ID: 4591602
[No Abstract] [Full Text] [Related]
27. Controlled cross-over comparison of isofloxythepin and perphenazine in the treatment of schizophrenic psychoses.
Svestka J; Náhunek K; Cesková E; Rysánek R; Balsíková J
Act Nerv Super (Praha); 1989 Apr; 31(1):32-4. PubMed ID: 2571218
[No Abstract] [Full Text] [Related]
28. [Influencing of biological and immunologic pregnancy reactions by psychotropic drugs].
Radzuweit H; Knorr W
Endokrinologie; 1969; 54(1):111-7. PubMed ID: 5358570
[No Abstract] [Full Text] [Related]
29. A double-blind comparison of AL-1021 and chlorpromazine in hospitalized schizophrenics.
Gendron JL; Zimmermann RL; Schiele BC
Curr Ther Res Clin Exp; 1973 Jun; 15(6):333-6. PubMed ID: 4197258
[No Abstract] [Full Text] [Related]
30. A controlled clinical trial of amitriptyline added to perphenazine in the treatment of depressed schizophrenics [proceedings].
Prusoff BA; Williams DH; Weissman MM; Astrachan BM
Psychopharmacol Bull; 1979 Apr; 15(2):80-1. PubMed ID: 373008
[No Abstract] [Full Text] [Related]
31. Clinical evaluation of neuroleptic drug action, particularly considering butyrophenones.
Kristjansen P
Acta Psychiatr Scand Suppl; 1966; 191():171-7. PubMed ID: 5336724
[No Abstract] [Full Text] [Related]
32. A pilot study of AL-449 in chronic schizophrenic patients.
Sugerman AA
Curr Ther Res Clin Exp; 1968 Oct; 10(10):533-6. PubMed ID: 4971469
[No Abstract] [Full Text] [Related]
33. Controlled study of BL-KR140 on chronic anergic schizophrenic patients stabilized with a neuroleptic compound.
Dim BH; Kurland AA
Curr Ther Res Clin Exp; 1968 Jun; 10(6):288-91. PubMed ID: 4969835
[No Abstract] [Full Text] [Related]
34. [Radioprotective properties of butyrophenone derivatives].
Uray Z; Farcasanu M; Maniu M
Agressologie; 1970; 11(4):357-60. PubMed ID: 5485665
[No Abstract] [Full Text] [Related]
35. Controlled cross-over comparison of carbamazepine with perphenazine in schizophrenic psychoses.
Svestka J; Cesková E; Rysánek R; Náhunek K
Act Nerv Super (Praha); 1989 Dec; 31(4):276-7. PubMed ID: 2576922
[No Abstract] [Full Text] [Related]
36. The effect of a protriptyline-perphenazine combination in chronic psychiatric patients.
St-Jean A; Ban TA; Scott J
Curr Ther Res Clin Exp; 1966 Oct; 8(10):483-6. PubMed ID: 4961168
[No Abstract] [Full Text] [Related]
37. [Study of the clinical effects of sulpiride and perphenazine in 82 schizophrenic patients by the double blind method].
Asada S; Ishimaru T; Kubo S; Kodama H; Masuda K
Encephale; 1976; 2(1):73-83. PubMed ID: 770152
[TBL] [Abstract][Full Text] [Related]
38. [Clinical effects of the butyrophenones. Floropipamide (Dipiperon), methylperon (Buronil), trifluperidol (Psicoperidol)].
Kristjansen P
Nord Psykiatr Tidsskr; 1968; 22(3):235-48. PubMed ID: 5711258
[No Abstract] [Full Text] [Related]
39. [Clinical comparison of methophenazine and perphenazine in schizophrenia. A controlled study. Effects on the photomyoclonic threshold].
Náhunek K; Svestka J; Misurec J
Act Nerv Super (Praha); 1967 Nov; 9(4):404-5. PubMed ID: 4889075
[No Abstract] [Full Text] [Related]
40. The position of trifluoperazine in the group of neuroleptics (a controlled clinical comparative study).
Svestka J; Náhunek K; Rodová A; Cesková E
Act Nerv Super (Praha); 1975 Sep; 17(3):208. PubMed ID: 1106107
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
